CIK 0001427570
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Vyome Holdings, Inc
Sign in to watch- Ticker
- HIND
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 949-429-6680
- Business address
- 1001 CALLE AMANECER, SAN CLEMENTE, CA, 92673
- Former names
- ReShape Lifesciences Inc., OBALON THERAPEUTICS INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Insider Changes in Ownership
- 4 Grant or award VP of Quality Assurance acquired 20,377 shares (grant or award)
- 4 Grant or award VP of Finance acquired 21,875 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 65,000 shares (grant or award)
- 4 Grant or award VP of Reg. and Clin. Affairs acquired 15,000 shares (grant or award)
- 4 Grant or award VP Research and Development acquired 17,938 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 45,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award President & CEO acquired 2,987 shares (grant or award)
- 4 Grant or award VP Research and Development acquired 2,743 shares (grant or award)
- 4 Grant or award Chief Technology Officer acquired 2,622 shares (grant or award)
- 4 Derivatives Options or other derivatives
Page 8 of 13 · 243 filings